The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Open accessAbstract
Cancer at single-cell resolution: Single-cell sequencing can illuminate the genetic properties of brain cancers and reveal heterogeneity within a tumor. Patel et al. examined the genome sequence of single cells isolated from brain glioblastomas. The findings revealed shared chromosomal changes but also extensive transcription variation, including genes related to signaling, which represent potential therapeutic targets. The authors suggest that the variation in tumor cells reflects neural development and that such variation among cancer cells may prove to have clinical significance. Science , this issue p. 1396
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“First, in contexts such as development and physiology, some facets of cellular identity are transient in time and space. Temporal processes may, for example, progress along one or more trajectories (e.g., differentiation); oscillate continuously between cellular states (e.g., the cell cycle98,99 or circadian rhythm100); or be influenced by the physical position and neighborhood of the cell71,93.”
From Revealing the vectors of cellular identity with single-cell genomics (2016) · cites this paper as [99]
Experimental — accuracy not yet measuredIn the citing paper
“Almost all previous work quantifying differences between single-cell datasets relies on discrete partitioning of the data before downstream analysis9–16.”
From Quantifying the effect of experimental perturbations at single-cell resolution (2021) · cites this paper as [9]
In the citing paper
“Recent studies have successfully applied similar approaches to single-cell data, for example, by Patel et al. [36] to identify gene signatures and TFs that correlate with the stemness gradient in glioblastoma”
From Mapping gene regulatory networks from single-cell omics data (2018) · cites this paper as [36]
In the citing paper
“Several studies inferred the cell cycle phase of individual cells from single-cell RNA-seq data30,35,97,99, relying on transcriptional signatures of discrete phases from earlier bulk profiling experiments146.”
From Revealing the vectors of cellular identity with single-cell genomics (2016) · cites this paper as [99]
In the citing paper
“single-cell profiles provide a near-continuous sampling and show high conservation across cell types and species30,97,99”
From Revealing the vectors of cellular identity with single-cell genomics (2016) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C. E., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,564
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,517
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Cited by
Sorted by citations
Items 801–900 of 1,018
Mumme, H., Thomas, B. E., Bhasin, S. S., Krishnan, U., Dwivedi, B., Perumalla, P., Sarkar, D., Ulukaya, G. B., Sabnis, H. S., Park, S. I., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41994-0 · Cited by 91
Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches
Miranda, A., Blanco‐Prieto, M. J., Sousa, J., Pais, A. A. C. C., & Vitorino, C. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.056 · Cited by 87
Single cell RNA-seq highlights a role for a partial EMT in head and neck cancer
Puram, S. V., Parikh, A. S., & Tirosh, I. (2018) · Molecular & Cellular Oncology · doi:10.1080/23723556.2018.1448244 · Cited by 87
Self-citationSystems Immunology: Learning the Rules of the Immune System
Villani, A., Sarkizova, S., & Hacohen, N. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053035 · Cited by 89
Zhang, J., Guan, M., Wang, Q., Zhang, J., Zhou, T., & Sun, X. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz040 · Cited by 85
P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs
Zhao, Y., Li, Y., Sheng, J., Wu, F., Li, K., Huang, R. S., Wang, X., Jiao, T., Guan, X., Lu, Y., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1375-9 · Cited by 85
Caron, M., St-Onge, P., Sontag, T., Wang, Y. C., Richer, C., Ragoussis, J., Sinnett, D., & Bourque, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-64929-x · Cited by 83
Wang, G., Yao, H., Gong, Y., Lu, Z., Pang, R., Li, Y., Yuan, Y., Song, H., Liu, J., Jin, Y., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh2724 · Cited by 86
Gao, Z., Xu, J., Yang, F., Qi, Y., Wang, S., Zhao, S., Guo, X., Xue, H., Deng, L., Zhao, R., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02431-0 · Cited by 86
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome
Parry, E. M., Leshchiner, I., Guièze, R., Johnson, C., Tausch, E., Parikh, S. A., Lemvigh, C. K., Broséus, J., Hergalant, S., Messer, C., et al. (2023) · Nature Medicine · doi:10.1038/s41591-022-02113-6 · Cited by 87
Using droplet digital PCR to analyzeMYCNandALKcopy number in plasma from patients with neuroblastoma
Lodrini, M., Sprüssel, A., Astrahantseff, K., Tiburtius, D., Konschak, R., Lode, H. N., Fischer, M., Keilholz, U., Eggert, A., & Deubzer, H. E. (2017) · Oncotarget · doi:10.18632/oncotarget.19076 · Cited by 87
Cantanhede, I. G., & de Oliveira, J. R. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-15045-w · Cited by 84
The microcosmos of intratumor heterogeneity: the space-time of cancer evolution
Janiszewska, M. (2019) · Oncogene · doi:10.1038/s41388-019-1127-5 · Cited by 90
Transcription and Beyond: Delineating FOXG1 Function in Cortical Development and Disorders
Hou, P., hAilín, D. Ó., Vogel, T., & Hanashima, C. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00035 · Cited by 82
HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity
Karagiannis, D., & Rampias, T. N. (2021) · Cancers · doi:10.3390/cancers13143575 · Cited by 88
Enhance explainability of manifold learning
Han, H., Li, W., Wang, J., Qin, G., & Qin, X. (2022) · Neurocomputing · doi:10.1016/j.neucom.2022.05.119 · Cited by 83
Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments
Feldman, L. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1384249 · Cited by 97
Single-cell RNA sequencing identifies distinct mouse medial ganglionic eminence cell types
Chen, Y.-J. J., Friedman, B. A., Ha, C., Durinck, S., Liu, J., Rubenstein, J. L. R., Seshagiri, S., & Modrusan, Z. D. (2017) · Scientific Reports · doi:10.1038/srep45656 · Cited by 80
Deep Learning AI Applications in the Imaging of Glioma
Zlochower, A. B., Chow, D. S., Chang, P. D., Khatri, D., Boockvar, J. A., & Filippi, C. G. (2020) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000237 · Cited by 83
Li, R., Zhao, H., Huang, X., Zhang, J., Bai, R., Zhuang, L., Wen, S., Wu, S., Zhou, Q., Li, M., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01568-8 · Cited by 84
Single cell deciphering of progression trajectories of the tumor ecosystem in head and neck cancer
Liu, Z. L., Meng, X., Bao, R., Shen, M. Y., Sun, J. J., Chen, W. D., Liu, F., & He, Y. (2024) · Nature Communications · doi:10.1038/s41467-024-46912-6 · Cited by 87
The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1
Romero, R., Chu, T., González-Robles, T. J., Smith, P., Xie, Y., Kaur, H., Yoder, S., Zhao, H., Mao, C., Kang, W., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00838-6 · Cited by 95
Tumor‐targeted nanotherapeutics: overcoming treatment barriers for glioblastoma
Wadajkar, A. S., Dancy, J. G., Hersh, D. S., Anastasiadis, P., Tran, N. L., Woodworth, G. F., Winkles, J. A., & Kim, A. J. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1439 · Cited by 85
Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms
Wang, J., & Bettegowda, C. (2016) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.08.007 · Cited by 87
Hypoxia drives transient site-specific copy gain and drug-resistant gene expressionPreprint
Black, J. C., Atabakhsh, E., Kim, J., Biette, K. M., Rechem, C. V., Ladd, B., Burrowes, P. D., Donado, C. A., Mattoo, H., Kleinstiver, B. P., et al. (2015) · Genes & Development · doi:10.1101/gad.259796.115 · Cited by 87
Dzaye, O., Hu, F., Derkow, K., Haage, V. C., Euskirchen, P., Harms, C., Lehnardt, S., Synowitz, M., Wolf, S. A., & Kettenmann, H. (2016) · Journal of Neuropathology and Experimental Neurology · doi:10.1093/jnen/nlw016 · Cited by 68
Cancer cell reprogramming: a promising therapy converting malignancy to benignity
Gong, L., Yan, Q., Zhang, Y., Fang, X., Liu, B., & Guan, X. (2019) · 癌症:英文版 · doi:10.1186/s40880-019-0393-5 · Cited by 83
Tawil, N., Bassawon, R., Meehan, B., Nehme, A., Montermini, L., Gayden, T., Jay, N. D., Spinelli, C., Chennakrishnaiah, S., Choi, D., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002998 · Cited by 82
Self-citationGlioblastoma Microenvironment and Cellular Interactions
Crivii, C.-B., Boșca, A. B., Melincovici, C. S., Constantin, A.-M., Mărginean, M., Dronca, E., Suflețel, R., Gonciar, D., Bungărdean, M., & Șovrea, A. (2022) · Cancers · doi:10.3390/cancers14041092 · Cited by 81
Molecular subtypes of ALS are associated with differences in patient prognosis
Eshima, J., O’Connor, S. A., Marschall, E., Bowser, R. P., Plaisier, C. L., & Smith, B. S. (2023) · Nature Communications · doi:10.1038/s41467-022-35494-w · Cited by 81
Using single‐cell multiple omics approaches to resolve tumor heterogeneity
Ortega, M. A., Poirion, O., Zhu, X., Huang, S., Wolfgruber, T. K., Sebra, R., & Garmire, L. X. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0177-y · Cited by 81
Zepecki, J. P., Snyder, K. M., Moreno, M. M., Fajardo, E. J., Fiser, A., Ness, J. K., Sarkar, A., Toms, S. A., & Tapinos, N. (2018) · Oncogene · doi:10.1038/s41388-018-0546-z · Cited by 81
Organoid Models of Glioblastoma and Their Role in Drug Discovery
Rybin, M. J., Ivan, M. E., Ayad, N. G., & Zeier, Z. R. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.605255 · Cited by 83
Rao, R., Han, R., Ogurek, S., Xue, C., Wu, L. M. N., Zhang, L., Zhang, L., HU, J. L., Phoenix, T. N., Waggoner, S. N., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab228 · Cited by 83
Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche
Boesch, M., Sopper, S., Zeimet, A. G., Reimer, D., Gastl, G. A., Ludewig, B., & Wolf, D. G. F. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.10.003 · Cited by 81
PyMINEr Finds Gene and Autocrine-Paracrine Networks from Human Islet scRNA-Seq
Tyler, S. R., Rotti, P. G., Sun, X., Yi, Y., Xie, W., Winter, M. C., Flamme‐Wiese, M. J., Tucker, B. A., Mullins, R. F., Norris, A. W., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.063 · Cited by 77
Chen, X., Litzenburger, U. M., Wei, Y., Schep, A. N., LaGory, E. L., Choudhry, H., Giaccia, A. J., Greenleaf, W. J., & Chang, H. Y. (2018) · Nature Communications · doi:10.1038/s41467-018-07115-y · Cited by 80
Single-cell sequencing and its applications in head and neck cancer
Qi, Z., Barrett, T. F., Parikh, A. S., Tirosh, I., & Puram, S. V. (2019) · Oral Oncology · doi:10.1016/j.oraloncology.2019.104441 · Cited by 82
Self-citationImmunology in the Era of Single-Cell Technologies
Efremova, M., Vento‐Tormo, R., Park, J.-E., Teichmann, S. A., & James, K. R. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090419-020340 · Cited by 80
The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy
Desland, F. A., & Hormigo, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197358 · Cited by 82
Mitchell, K., Troike, K. M., Silver, D. J., & Lathia, J. D. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa259 · Cited by 84
Zhou, S., Huang, Y., Liu, H., Zhou, X., Yuan, M., Hou, F., Wang, L., & Jiang, W. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.12.018 · Cited by 78
Herrera, A. M., Cheng, A., Mimitou, E. P., Seffens, A., George, D. D., Bar‐Natan, M., Heguy, A., Ruggles, K. V., Scher, J. U., Hymes, K. B., et al. (2021) · Blood · doi:10.1182/blood.2020009346 · Cited by 81
Bridging live-cell imaging and next-generation cancer treatment
Alieva, M., Wezenaar, A. K. L., Wehrens, E. J., & Rios, A. C. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00610-5 · Cited by 84
Hai, P., Imai, T., Xu, S., Zhang, R., Aft, R., Zou, J., & Wang, L. V. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0376-5 · Cited by 80
Granatum: a graphical single-cell RNA-Seq analysis pipeline for genomics scientists
Zhu, X., Wolfgruber, T., Tasato, A., Arisdakessian, C. G., Garmire, D. G., & Garmire, L. X. (2017) · Genome Medicine · doi:10.1186/s13073-017-0492-3 · Cited by 80
Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells
Reitman, Z. J., Paolella, B. R., Bergthold, G., Pelton, K., Becker, S., Jones, R. E., Sinai, C. E., Malkin, H., Huang, Y., Grimmett, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11493-2 · Cited by 78
Self-citationDetrimental activation of AhR pathway in cancer: an overview of therapeutic strategies
Leclerc, D., Pires, A. S., Guillemin, G. J., & Gilot, D. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.12.003 · Cited by 82
Chen, P., Wang, Y., Li, J., Bo, X., Wang, J., Nan, L., Wang, C., Ba, Q., Liu, H., & Wang, H. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.462 · Cited by 79
Yang, T., Mochida, Y., Liu, X., Zhou, H., Xie, J., Anraku, Y., Kinoh, H., Cabral, H., & Kataoka, K. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00803-z · Cited by 80
Applications of Radiomics and Radiogenomics in High-Grade Gliomas in the Era of Precision Medicine
Kazerooni, A. F., Bagley, S. J., Akbari, H., Saxena, S., Bagheri, S., Guo, J. F., Chawla, S., Nabavizadeh, A., Mohan, S., Bakas, S., et al. (2021) · Cancers · doi:10.3390/cancers13235921 · Cited by 79
Chen, K., Reinshagen, C., van Schaik, T., Rossignoli, F., Borges, P., Mendonca, N. C., Abdi, R., Simon, B. G., Reardon, D. A., Wakimoto, H., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo4778 · Cited by 81
Self-citationTargeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells
Fujikawa, A., Sugawara, H., Tanaka, T., Matsumoto, M., Kuboyama, K., Suzuki, R., Tanga, N., Ogata, A., Masumura, M., & Noda, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-05931-8 · Cited by 75
Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells
Was, H., Krol, S. K., Rotili, D., Mai, A., Wojtas, B., Kaminska, B., & Maleszewska, M. (2019) · Clinical Epigenetics · doi:10.1186/s13148-018-0598-5 · Cited by 78
Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
Liu, F., Mischel, P. S., & Cavenee, W. K. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0005-2 · Cited by 78
Poirion, O., Zhu, X., Ching, T. H., & Garmire, L. X. (2018) · Nature Communications · doi:10.1038/s41467-018-07170-5 · Cited by 79
Reconstructing the molecular life history of gliomas
Barthel, F. P., Wesseling, P., & Verhaak, R. G. W. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1842-y · Cited by 86
Wang, L., Fan, J., Francis, J. M., Georghiou, G. P., Hergert, S., Li, S., Gambe, R. G., Zhou, C. W., Yang, C., Xiao, S., et al. (2017) · Genome Research · doi:10.1101/gr.217331.116 · Cited by 77
Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways
Kim, S. M., Roy, S. G., Chen, B., Nguyen, T. M., McMonigle, R. J., McCracken, A. N., Zhang, Y., Kofuji, S., Hou, J., Selwan, E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87148 · Cited by 77
Glioblastoma’s Next Top Model: Novel Culture Systems for Brain Cancer Radiotherapy Research
Caragher, S. P., Chalmers, A. J., & Gomez-Roman, N. (2019) · Cancers · doi:10.3390/cancers11010044 · Cited by 80
Extracellular Vesicle-Mediated Bilateral Communication between Glioblastoma and Astrocytes
Nieland, L., Morsett, L. M., Broekman, M. L. D., Breakefield, X. O., & Abels, E. R. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.10.014 · Cited by 77
Single‐cell transcriptomes reveal heterogeneity of high‐grade serous ovarian carcinoma
Hao, Q., Li, J., Zhang, Q., Xu, F., Xie, B., Lu, H., Wu, X., & Zhou, X. Y. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.500 · Cited by 76
Liu, X., Wang, X. M., Yang, Q., Luo, L., Liu, Z., Ren, X., Lei, K., Li, S., Xie, Z., Zheng, G., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2123 · Cited by 80
Chiaro, P. D., Nacci, L., Arco, F., Brandini, S., Polletti, S., Palamidessi, A., Donati, B., Soriani, C., Gualdrini, F., Frigè, G., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.02.017 · Cited by 80
Lee, S., Weiß, T., Bühler, M., Mena, J., Lottenbach, Z., Wegmann, R., Sun, M., Bihl, M., Augustynek, B., Baumann, S. P., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03224-y · Cited by 92
Unraveling the 3D genome: genomics tools for multiscale exploration
Risca, V. I., & Greenleaf, W. J. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.03.010 · Cited by 77
Variation is function: Are single cell differences functionally important?
Dueck, H., Eberwine, J. H., & Kim, J. (2015) · BioEssays · doi:10.1002/bies.201500124 · Cited by 84
Xu, C. A., Lopez, R., Mehlman, E., Regier, J., Jordan, M. I., & Yosef, N. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/532895 · Cited by 80
Exploiting single-cell expression to characterize co-expression replicability
Crow, M., Paul, A., Ballouz, S., Huang, Z. J., & Gillis, J. (2016) · Genome Biology · doi:10.1186/s13059-016-0964-6 · Cited by 76
Großmann, P., Gutman, D. A., Dunn, W. D., Holder, C. A., & Aerts, H. J. W. L. (2016) · BMC Cancer · doi:10.1186/s12885-016-2659-5 · Cited by 77
Current Trends of Microfluidic Single-Cell Technologies
Shinde, P., Mohan, L., Kumar, A. S., Dey, K., Maddi, A., Patananan, A. N., Tseng, F., Chang, H., Nagai, M., & Santra, T. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103143 · Cited by 79
McImpute: Matrix Completion Based Imputation for Single Cell RNA-seq Data
Mongia, A., Sengupta, D., & Majumdar, A. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00009 · Cited by 77
Jian, A., Jang, K., Manuguerra, M., Liu, S., MAGNUSSEN, J. S., & Ieva, A. D. (2021) · Neurosurgery · doi:10.1093/neuros/nyab103 · Cited by 79
Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq
Li, Q., Wang, R., Yang, Z., Li, W., Yang, J., Wang, Z., Bai, H., Cui, Y., Tian, Y., Wu, Z., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01089-9 · Cited by 82
Wang, Z., Wang, Y., Chang, M., Wang, Y., Liu, P., Wu, J., Wang, G., Tang, X., Hui, X., Liu, P., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad017 · Cited by 87
Machine learning reveals diverse cell death patterns in lung adenocarcinoma prognosis and therapy
Wang, S., Wang, R., Hu, D., Zhang, C.-X., Cao, P., & Huang, J. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00538-5 · Cited by 79
Genetic and Functional Diversity of Propagating Cells in Glioblastoma
Piccirillo, S. G. M., Colman, S., Potter, N. E., van Delft, F. W., Lillis, S., Carnicer, M.-J., Kearney, L., Watts, C., & Greaves, M. F. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.11.003 · Cited by 77
Cancer Metabolism: A Modeling Perspective
Ghaffari, P., Mardinoğlu, A., & Nielsen, J. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00382 · Cited by 76
Emerging circulating biomarkers in glioblastoma: promises and challenges
Touat, M., Durán-Peña, A., Alentorn, A., Lacroix, L., Massard, C., & Idbaïh, A. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1087315 · Cited by 77
Spinelli, C., Montermini, L., Meehan, B., Brisson, A. R., Tan, S., Choi, D., Nakano, I., & Rak, J. W. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1490144 · Cited by 76
KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice
Polson, E. S., Kuchler, V., Abbosh, C., Ross, E. M., Mathew, R. K., Beard, H. A., da Silva, B., Holding, A. N., Ballereau, S. J., Chuntharpursat‐Bon, E., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar2718 · Cited by 72
Self-citationCurrent State and Future Prospects of Immunotherapy for Glioma
Kamran, N., Alghamri, M. S., Núñez, F. J., Shah, D., Asad, A. S., Candolfi, M., Altshuler, D. B., Lowenstein, P. R., & Castro, M. G. (2018) · Immunotherapy · doi:10.2217/imt-2017-0122 · Cited by 77
Emerging approaches to study cell-cell interactions in tumor microenvironment
Nishida‐Aoki, N., & Gujral, T. S. (2019) · Oncotarget · doi:10.18632/oncotarget.26585 · Cited by 76
Kinaret, P., Serra, A., Federico, A., Kohonen, P. J., Nymark, P. E. H., Liampa, I., Ha, M. K., Choi, J., Jagiełło, K., Sanabria, N. M., et al. (2020) · Nanomaterials · doi:10.3390/nano10040750 · Cited by 79
New hints towards a precision medicine strategy for IDH wild-type glioblastoma
White, K., Connor, K., Clerkin, J., Murphy, B. M., Salvucci, M., O’Farrell, A. C., Rehm, M., O’Brien, D., Prehn, J. H. M., Niclou, S. P., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.08.2336 · Cited by 75
WNT Signaling as a Therapeutic Target for Glioblastoma
Latour, M., Her, N.-G., Kesari, S., & Nurmemmedov, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168428 · Cited by 75
Deep learning tackles single-cell analysis—a survey of deep learning for scRNA-seq analysis
Flores, M. A., Liu, Z., Zhang, T., Hasib, M. M., Chiu, Y., Ye, Z., Paniagua, K., Jo, S., Zhang, J., Gao, S., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab531 · Cited by 73
Xiao, Y., Wang, Z., Zhao, M., Deng, Y., Yang, M., Su, G., Yang, K., Qian, C., Hu, X., Liu, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.914236 · Cited by 74
Song, X., Xiong, A., Wu, F., Li, X., Wang, J., Jiang, T., Chen, P., Zhang, X., Zhao, Z., Liu, H., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006234 · Cited by 78
Spatial metabolomics reveals glycogen as an actionable target for pulmonary fibrosis
Conroy, L. R., Clarke, H. A., Allison, D. B., Valença, S. S., Sun, Q., Hawkinson, T. R., Young, L. E. A., Ferreira, J. E., Hammonds, A. V., Dunne, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38437-1 · Cited by 79
Perez, J. G., Tran, N. L., Rosenblum, M. G., Schneider, C. S., Connolly, N. P., Kim, A. J., Woodworth, G. F., & Winkles, J. A. (2015) · Oncogene · doi:10.1038/onc.2015.310 · Cited by 77
Dermawan, J. K. T., Hitomi, M., Silver, D. J., Wu, Q., Sandlesh, P., Sloan, A. E., Purmal, A. A., Gurova, K. V., Rich, J. N., Lathia, J. D., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2162 · Cited by 77
Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation
Fessler, E., & Medema, J. P. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.07.008 · Cited by 81
Do, T. D., Comi, T. J., Dunham, S. J. B., Rubakhin, S. S., & Sweedler, J. V. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04819 · Cited by 79
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma
Skaga, E., Kulesskiy, E., Fayzullin, A., Sandberg, C. J., Potdar, S., Kyttälä, A., Langmoen, I. A., Laakso, A., Gaál‐Paavola, E., Perola, M., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5861-4 · Cited by 75
Chen, J., Schlitzer, A., Chakarov, S., Ginhoux, F., & Poidinger, M. (2016) · Nature Communications · doi:10.1038/ncomms11988 · Cited by 72
Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer
Ma, D., Jiang, Y., Liu, X., Liu, Y., & Shao, Z. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4113-z · Cited by 74
Chow, D. S., Chang, P. D., Weinberg, B. D., Bota, D. A., Grinband, J., & Filippi, C. G. (2017) · American Journal of Roentgenology · doi:10.2214/ajr.17.18754 · Cited by 73
Civita, P., Leite, D. M., & Pilkington, G. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236017 · Cited by 74
Single-cell RNA-seq clustering: datasets, models, and algorithms
Peng, L., Tian, X., Tian, G., Xu, J., Huang, X., Weng, Y., Yang, J., & Zhou, L. (2020) · RNA Biology · doi:10.1080/15476286.2020.1728961 · Cited by 77
Metadata
- Authors
- Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., Louis, D. N., Rozenblatt-Rosen, O., Suvà, M. L., Regev, A., & Bernstein, B. E.
- Affiliations
- Broad Institute (US)
- Harvard University (US)
- Broad Institute of Harvard and Massachusetts Institute of Techonology (MIT), Cambridge, MA 02142, USA.
- Corresponding author
- Patel, Anoop P.
- Tirosh, Itay
- Suvà, Mario L.
- Regev, Aviv
- Bernstein, Bradley E.
- ORCID
- Venue
- Science
- Published
- 2014-06-20
- Volume
- 344
- Issue
- 6190
- Pages
- 1396-1401
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4123637
- OpenAlex
- W1792532087
- Cited by
- 5,063
- References
- 47
- Citations by year
- 2026: 437 · 2025: 505 · 2024: 545 · 2023: 514 · 2022: 501 · 2021: 538 · 2020: 521 · 2019: 376 · 2018: 352 · 2017: 306 · 2016: 251 · 2015: 167 · 2014: 43
- FWCI
- 104.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- Howard Hughes Medical Institute
- National Human Genome Research Institute (U54HG006991)
- National Cancer Institute (U24CA180922, P50CA165962)
- National Institute of Neurological Disorders and Stroke (R01NS032677, R25NS065743)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- glioblastoma, intratumoral heterogeneity, tumor heterogeneity, cancer stemness, transcriptional programs, oncogenic signaling, hypoxia, immune response, glioblastoma subtypes, prognostic factors, single-cell transcriptomics
- MeSH terms
- Brain Neoplasms, Glioblastoma, Humans, Prognosis, RNA, Messenger, Genetic Variation, Sequence Analysis, RNA, Gene Expression Profiling, Single-Cell Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review